Literature DB >> 10685991

Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants.

J R McColm1, B J Stenson, N Biermasz, N McIntosh.   

Abstract

BACKGROUND: Interleukin 10 (IL-10) is a cytokine that downregulates inflammation, in part by reducing the production of the proinflammatory cytokines IL-1beta and IL-8. It has been suggested that an inability to produce IL-10 might predispose preterm infants to develop chronic lung disease. AIM: To measure IL-10, IL-1beta, and IL-8 in bronchoalveolar lavage fluid from ventilated preterm infants in a prospective cohort study. PATIENTS: 17 consecutive newborn infants < or = 29 weeks' gestational age (median, 25; 9 boys) who were ventilated from birth underwent daily bronchoalveolar lavage sampling.
RESULTS: 102 samples were collected, of which 57 contained IL-10 in amounts that were comparable with those found previously in ventilated term infants with respiratory failure. Chronic lung disease developed in 9 of the 11 survivors and all 9 infants had produced IL-10. IL-1beta and IL-8 were detected in nearly all samples and were raised throughout the course of sample collection.
CONCLUSION: IL-10 is readily detectable in early bronchoalveolar lavage samples from ventilated preterm infants, although it remains unclear whether this cytokine has any influence on the development of chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685991      PMCID: PMC1721060          DOI: 10.1136/fn.82.2.f156

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  30 in total

Review 1.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group.

Authors: 
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

2.  Adhesive interactions in the immune system.

Authors:  E J Brown
Journal:  Trends Cell Biol       Date:  1997-07       Impact factor: 20.808

3.  A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease.

Authors:  K P Jones; J H Edwards; S P Reynolds; T J Peters; B H Davies
Journal:  Eur Respir J       Date:  1990-02       Impact factor: 16.671

4.  Neonatal chronic lung disease in extremely immature baboons.

Authors:  J J Coalson; V T Winter; T Siler-Khodr; B A Yoder
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

5.  Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage.

Authors:  T W Marcy; W W Merrill; J A Rankin; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-06

6.  Short-term and long-term effects of serial bronchoalveolar lavages in a nonhuman primate model.

Authors:  F Krombach; E Fiehl; D Burkhardt; R Rienmüller; G König; B C Adelmann-Grill; H Idel; M Rosenbruch
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Changing patterns in neonatal respiratory diseases.

Authors:  D J Field; A D Milner; I E Hopkin; R J Madeley
Journal:  Pediatr Pulmonol       Date:  1987 Jul-Aug

9.  Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf).

Authors:  C P Speer; B Götze; T Curstedt; B Robertson
Journal:  Pediatr Res       Date:  1991-07       Impact factor: 3.756

10.  Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns.

Authors:  C A Jones; R G Cayabyab; K Y Kwong; C Stotts; B Wong; H Hamdan; P Minoo; R A deLemos
Journal:  Pediatr Res       Date:  1996-06       Impact factor: 3.756

View more
  10 in total

1.  Early inflammation in the absence of overt infection in preterm neonates exposed to intensive care.

Authors:  Brent A Chang; Qing Huang; Joanne Quan; Vann Chau; Mihoko Ladd; Eddie Kwan; Deborah E McFadden; Thierry Lacaze-Masmonteil; Steven P Miller; Pascal M Lavoie
Journal:  Cytokine       Date:  2011-09-21       Impact factor: 3.861

2.  Does the use of 50% oxygen at birth in preterm infants reduce lung injury?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

Review 3.  Oxidative stress and peripartum outcomes (Review).

Authors:  Zsuzsanna Simon-Szabo; Erzsebet Fogarasi; Eniko Nemes-Nagy; Lorand Denes; Mircea Croitoru; Bela Szabo
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

4.  Decreased neutrophil apoptosis in tracheal fluids of preterm infants at risk of chronic lung disease.

Authors:  J Oei; K Lui; H Wang; R Henry
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

5.  Tools for assessing lung fluid in neonates with respiratory distress.

Authors:  So Jin Yoon; Jung Ho Han; Kee Hyun Cho; Joonsik Park; Soon Min Lee; Min Soo Park
Journal:  BMC Pediatr       Date:  2022-06-20       Impact factor: 2.567

6.  Transcriptional control of cytokine release from monocytes of the newborn: effects of endogenous and exogenous interleukin-10 versus dexamethasone.

Authors:  Lina A Chusid; Lucy Pereira-Argenziano; Veronika Miskolci; Ivana Vancurova; Dennis Davidson
Journal:  Neonatology       Date:  2009-08-28       Impact factor: 4.035

7.  Interleukin-10 versus dexamethasone: effects on polymorphonuclear leukocyte functions of the newborn.

Authors:  Brett V Citarella; Veronika Miskolci; Ivana Vancurova; Dennis Davidson
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

Review 8.  Oxidative stress and bronchopulmonary dysplasia.

Authors:  Serafina Perrone; Maria Luisa Tataranno; Giuseppe Buonocore
Journal:  J Clin Neonatol       Date:  2012-07

9.  Cytokine profiles at birth and the risk of developing severe respiratory distress and chronic lung disease.

Authors:  Majeda S Hammoud; Raj Raghupathy; Nahla Barakat; Hoda Eltomi; Deena Elsori
Journal:  J Res Med Sci       Date:  2017-05-30       Impact factor: 1.852

10.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.